An interventional study of Implantation of trapeziometacarpal prosthesis and Trapeziectomy with Capsuloplasty in Thumb Osteoarthritis, Thumb Carpometacarpal Joint Osteoarthritis and Carpometacarpal (CMC) Joint Arthritis, sponsored by Uppsala University. Recruiting at 1 site in Sweden. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Uppsala University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this clinical trial is to learn if the surgical method with total joint arthroplasty, (TOUCH joint prosthesis), is as good as or better than the traditional surgical method, trapezectomy, to treat thumb base joint osteoarthritis.
The main questions it aims to answer are:
Does surgery with total joint arthroplasty provide better power grip and pinch grip strength compared to traditional surgery?
What is the long-term risk of complications for both methods?
Which method is more cost-effective for the healthcare system?
Researchers will compare total joint arthroplasty (TOUCH) to trapezectomy (a procedure where a bone in the thumb base is removed) to see which method provides the best results for the patient.
Participants will:
Be randomized to undergo either an operation with total joint arthroplasty or a trapezectomy.
Undergo an initial evaluation and a health economic cost analysis after one year.
Attend follow-up checkups at 2, 5, and 10 years post-surgery to evaluate long-term function and the durability of the prosthesis.
Background and Rationale:
Basal joint arthritis of the thumb (trapeziometacarpal osteoarthritis) is a common condition causing pain and reduced hand function. While trapeziectomy with ligament reconstruction/capsuloplasty has long been a gold standard, total joint arthroplasty, such as the TOUCH prosthesis, has gained popularity. However, there is a lack of high-quality prospective randomized controlled trials (RCTs) comparing these methods regarding long-term functional outcomes, complication rates, and cost-effectiveness. This study aims to compare the clinical and health-economic outcomes of total joint arthroplasty with TOUCH prosthesis versus trapeziectomy with capsuloplasty.
Study Design and Randomization:
This is a prospective, randomized controlled trial. Following informed consent obtained by the attending surgeon, participants are randomized to either:
Procedures and Follow-up
Data Management and Quality Assurance:
Data is collected and managed using REDCap (Research Electronic Data Capture) to ensure data integrity and validation. Physical informed consent forms are stored securely at the Department of Hand Surgery. Source data verification is performed by comparing registry data against electronic medical records and paper-based Case Report Forms (CRFs).
Sample Size and Power Calculation:
The primary outcome is Jamar grip strength at 12 months. Based on a Minimal Clinically Important Difference (MCID) of 6.5 kg and a standard deviation (SD) of 8.5 kg (derived from existing literature and pilot data), a power calculation (90% power, alpha 0.05, two-sided t-test) determined a requirement of 37 patients per group. To account for a 10% dropout rate, the total cohort size is set at 84 patients (42 per arm).
Health Economic Analysis:
A comprehensive health economic evaluation will be conducted to compare the total costs of both methods. This analysis includes:
The objective is to determine if the higher initial cost of the TOUCH prosthesis is offset by faster recovery, reduced sick leave, and improved long-term productivity.
Uppsala University is the lead sponsor of 390 studies on the registry; 86 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The criteria were revised on the registry on Oct 9, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
TOUCH Total Joint Arthroplasty (n=42). Implantation of TOUCH trapeziometacarpal prosthesis (Kerimedical). Soft bandage for 3 weeks postoperatively, followed by rehabilitation per national guidelines.
Device: Implantation of trapeziometacarpal prosthesis
Trapezectomy with capsuloplasty (n=42). Excision of trapezium with dorsal capsule flap capsuloplasty. Cast immobilization for 3 weeks postoperatively, followed by rehabilitation per national guidelines.
Procedure: Trapeziectomy with Capsuloplasty
Surgical implantation of the TOUCH trapeziometacarpal total joint prosthesis (Kerimedical). The prosthesis consists of an uncemented stainless steel stem inserted into the first metacarpal and a dual cup mobility system with a polyethylene ball articulating against a metal cup fixed in the trapezium. The stem is available in straight or 15-degree angled neck configurations. Postoperative management consists of a stable soft dressing for 3 weeks to allow early controlled mobilization, followed by a standardized hand therapy rehabilitation protocol.
Also known as: TOUCH Dual-Mobility Prosthesis
Surgical excision of the trapezium bone (trapeziectomy) followed by capsuloplasty using a distally based dorsal capsular flap, without tendon interposition. The capsular flap is sutured to stabilize the base of the first metacarpal. No implant or tendon graft is used. Postoperatively, a cast immobilizing the thumb in functional position is applied for 3 weeks, followed by a standardized hand therapy rehabilitation protocol.
Hand grip strength
Hand grip strength (JAMAR dynamometer) at 12 months post operatively
Time frame: Measured at 12 months postoperatively
Key-pinch grip strength
Key-pinch strength measured by pinch-gauge in kilograms
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Pinch grip strength
3-finger pinch strength measured by pinch gauge in kilograms
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Postoperative Pain Intensity on a Numeric Rating Scale (NRS)
Pain measured with the Numerical Rating Scale (NRS) at rest and load, where 0 is "no pain" and 10 is "worst imaginable pain"
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Range of movement
Range of movement of thumb measured by physiotherapist. Extension, flexion, volar abduction, radial abduction. In degrees.
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Metacarpophalangeal (MCP)-joint hyperextension
Radiographic MCP-joint hyperextension (Z-deformity)
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Complications
Complications, such as trigger thumb, de Quervain's, reoperation, and infection, reported within 12 months of surgery.
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Use of analgesics
Total usage of analgesic during the post operative period.
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Duration of sick leave
Total duration of sick leave.
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Patient-reported outcomes EQ-5D
Patient-reported outcome of the hand surgery using validated questionnaire EQ-5D
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Patient-reported outcomes PRWHE
Patient-reported outcome of the hand surgery using validated questionnaire PRWHE
Time frame: Measured at 6 weeks, 12 weeks, 12 months, 2 years, 5 years and 10 years postoperatively
Plan to share: Yes — De-identified individual participant data that underlie the results reported in this article (text, tables, figures, and appendices) will be made available to researchers who provide a methodologically sound proposal. Data will be available beginning 6 months and ending 5 years after publication. Requests should be directed to Central contact person. To gain access, data requestors will need to sign a data access agreement and provide proof of approval from the Swedish Ethical Review Authority.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: Beginning 6 months and ending 5 years after publication
Access criteria: Access will be granted to qualified academic researchers who provide a methodologically sound scientific proposal. The request must be consistent with the informed consent provided by the participants. Access requires a formal Data Sharing Agreement (DSA) and a valid ethical approval from the Swedish Ethical Review Authority (Etikprövningsmyndigheten). The requesting party must also demonstrate that they have the necessary infrastructure to handle sensitive data according to GDPR
Started Sep 2026 (actual). Primary completion is estimated for May 2030, 44 months after the start.
Start moved once since we started tracking on Sep 25, 2026: Jul 2026 → Sep 2026, on Oct 9, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Capillary Malformations, Congenital, 1